Spravato nasal spray for depression is out of reach | Syndicated Columnists
Q. I was a participant in a phase 3 clinical trial for esketamine, which came to market as the nasal spray Spravato. The Food and Drug Administration approved it for treatment-resistant major depression, a condition I’ve suffered from for 15+ years. The effect was profound: an immediate relief of all suicidal ideation and brain fog, […]
Spravato nasal spray for depression is out of reach | Syndicated Columnists Read More »